Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Capital Employed (2016 - 2025)

Abeona Therapeutics has reported Return on Capital Employed over the past 15 years, most recently at 0.46% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.46% for Q4 2025, up 20.0% from a year ago — trailing twelve months through Dec 2025 was 0.46% (up 20.0% YoY), and the annual figure for FY2025 was 0.66%, up 25.0%.
  • Return on Capital Employed for Q4 2025 was 0.46% at Abeona Therapeutics, down from 0.38% in the prior quarter.
  • Over the last five years, Return on Capital Employed for ABEO hit a ceiling of 0.38% in Q3 2025 and a floor of 2.9% in Q3 2022.
  • Median Return on Capital Employed over the past 5 years was 0.82% (2023), compared with a mean of 0.98%.
  • Biggest five-year swings in Return on Capital Employed: crashed -232bps in 2022 and later skyrocketed 199bps in 2023.
  • Abeona Therapeutics' Return on Capital Employed stood at 1.09% in 2021, then fell by -7bps to 1.16% in 2022, then rose by 22bps to 0.91% in 2023, then grew by 28bps to 0.65% in 2024, then surged by 30bps to 0.46% in 2025.
  • The last three reported values for Return on Capital Employed were 0.46% (Q4 2025), 0.38% (Q3 2025), and 0.54% (Q2 2025) per Business Quant data.